Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01665846 · ClinicalTrials.gov registry record · Phase 1
Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive Disorders
A Phase 1 study, sponsored by University of Hawaii.
- Completed
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT01665846 is a Phase 1 study that has completed, run by University of Hawaii. The registered enrollment target is 4 participants.
The verdict
NCT01665846, a Phase 1 study, has completed, sponsored by University of Hawaii.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to describe the radiologic findings on brain MRI after ferumoxytol administration in HIV-infected patients with cognitive impairment.
Interventions
- DRUG Ferumoxytol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2011-07 |
| Est. Completion | 2012-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01665846
The ClinicalTrials.gov registry entry for NCT01665846 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Hawaii, which has 77 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ferumoxytol is the first listed.
NCT01665846 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01665846 about?
NCT01665846 is a clinical study titled "Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive Disorders". The purpose of this study is to describe the radiologic findings on brain MRI after ferumoxytol administration in HIV-infected patients with cognitive impairment.
What is the current status of trial NCT01665846?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2011-07. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01665846?
The interventions under investigation include: Ferumoxytol (DRUG).
Who is sponsoring clinical trial NCT01665846?
This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.